天美传媒 leads Texas in dementia research, care and prevention
The Glenn Biggs Institute for Alzheimer鈥檚 and Neurodegenerative Diseases at 天美传媒, in partnership with UT Rio Grande Valley, is home to the South Texas Alzheimer鈥檚 Disease Research Center, Texas鈥 only National Institute on Aging (NIA)-designated Alzheimer鈥檚 Disease Research Center鈥攐ne of just 35 nationwide.
The Biggs Institute for Alzheimer鈥檚 and Neurodegenerative Diseases is the region鈥檚 first comprehensive center dedicated to improving discovery of the basic abnormalities in Alzheimer鈥檚 disease and then developing new therapeutic strategies for treatment of all dementias through patient care, innovative research and clinical trials. Currently, there are nearly 7 million Americans living with Alzheimer鈥檚. This number is expected to almost double in the next 26 years. Texas ranks fourth in the number of Alzheimer鈥檚 cases and second in the number of deaths.
The University of Texas Health Science Center at San Antonio will open a $100 million Center for Brain Health in 2025. The center is expected to enhance the institution鈥檚 Glenn Biggs Institute for Alzheimer鈥檚 and Neurodegenerative Diseases and the Department of Neurology within the Joe R. and Teresa Lozano Long School of Medicine. The new center will feature an imaging suite equipped with a 7-Telsa magnet scanner and dedicated clinical spaces for treatment and rehabilitation.
The Biggs Institute works with academic, nonprofit and community partners across Texas to provide access to research opportunities, diagnosis and care.
Only NIA-designated Alzheimer鈥檚 Disease Research Center in Texas
Physicians, scientists and supportive staff working together to provide you comprehensive care
Center for Brain Health (opening in 2025), will be a comprehensive hub for brain research, collaboration and discoveries
In The News
天美传媒 researchers explore new diagnostic tools, genetic roots for early-onset dementia
Dementia is one of the most challenging medical and societal issues of our time, affecting memory, thinking and independence for millions of families worldwide. At 天美传媒, researchers and clinicians are taking new steps to change that story through research, genetic insights and compassionate, integrated care. At the heart of this mission is [鈥
In recent years, research into cannabis and its main psychoactive ingredient, 螖鈦-tetrahydrocannabinol (THC), has unearthed medical benefits including anti-inflammatory and neuroprotective properties. However, THC is also known to negatively affect learning and memory, limiting its potential clinical usefulness, particularly in disorders of the brain. Now, a new study led by Chu Chen, PhD, professor in [鈥